The Life Science Cluster

✨ Reflecting on InLifeScience 2024: A day of insight and collaboration On Wednesday we gathered at Forskningsparken - Oslo Science Park for an inspiring and thought-provoking day focused on the future of global and planetary health, and the role of life sciences. The event featured engaging keynotes, insightful panels, and lively discussions around AI, immunology, women’s health, bioresources, nutrition, sustainability, and health innovation. From exploring the potential of AlphaFold, Rosettafold and CRISPR with Ishita Barua, MD PhD and Sigrid Bratlie, to reflecting on planetary health solutions with Olav Kjørven, to delving into data-driven nanobody design with Roberto Spreafico, our audience experienced groundbreaking advancements in the industry. The life science export panel emphasized the importance of strategic partnerships, robust funding, and leveraging existing knowledge when exploring new markets. In the bioresources session, speakers stressed the urgent need for a paradigm shift in utilizing the earth's limited resources. They explored strategies for turning byproducts from the food industry into valuable materials, innovative technologies for sustainable production, and the role of nutrition in shaping healthier and more sustainable food systems. In the health session, discussions focused on translating science into societal impact through industry-academia collaborations and how strong agreements ensure excellent science, industrial usefulness, and shared benefits. The women’s health session discussed both women-only diseases like endometriosis, and the joint largest killers such as stroke and heart disease. The bias presents both through research choices and clinical trials, to understanding of symptoms and treatment. The immunology session delved into the vast opportunity space presented by our immune system, and how the “twin revolution” AI x biotech can result in much faster and more tailored molecules for treatment of disease. The investor panel highlighted the importance of capital efficiency and strategic partnerships, emphasizing on building early, long-term investor relationships. Valuable remarks from Anita Leirvik North, Vice Mayor for Culture and Business Development, and Ole Johan Borge, Director of Health and Public Sector Norges forskningsråd, closed the event. Ole Johan Borge reflected: "Bringing together students, researchers, start-ups and industry professionals is crucial. These connections and shared experiences are what drive innovation and push the life science sector forward." 🙏 A huge thank you to all our speakers, panellists, moderators, collaborators, program committee, and participants! Your insights and energy made this event a true success. Tekna | Tone Juel | Ørjan Leiknes Apeland | Marius Widerøe | Solveig Fossum-Raunehaug | Hanne Mette Kristensen | Delphine Costa | Eva Veiseth-Kent | Carl Henrik Görbitz | Terje Hekkelstrand 📸 Benjamin Dyhre | Anne-Marie Korseberg Stokke

We’re excited to support the national health export initiative launched by Innovation Norway, with a starting focus on expanding into the German market. Collaboration across Norway’s health clusters will be key to driving the export of our innovative health solutions! 

A big thank you to all who attended the InLifeScience 2024 conference! - Thank you program committee Eva Veiseth-Kent/Nofima , Terje Hekkelstrand/Thermo Fisher Scientific, Carl Henrik Görbitz/Universitetet i Oslo (UiO), Marius Widerøe/Norges teknisk-naturvitenskapelige universitet (NTNU). - Thank you session & panel moderators Ørjan Leiknes Apeland/Curida Ås, Solveig Fossum-Raunehaug/NMBU - Norwegian University of Life Sciences, Marius Widerøe/NTNU, Tone Varslot Stave/Innovasjon Norge. -Thank you keynotes, speakers & panelists Ishita Barua, MD PhD Sigrid Bratlie Olav Kjørven Roberto Spreafico Stefan Kernstock Torsten Knüttel Mia Louise Kråkstad Hanne Haslene-Hox Else Charlotte Sandset Kristin Janett Løseth Liv Bjørnhaug Johansen Fridtjof Lund-Johansen Geir Kjetil Sandve Geir Åge Løset Herbert Altmann Bjørn Liaset Silje Båtsvik Risholm Adrián, Ingrid Dynna Trond Atle Smedsrud Kristin Hollung Lene Frost Andersen Georgina Askeland, PhD Erik Wold Anders Kapstad Ole Johan Borge

🌟𝗜𝗻𝗟𝗶𝗳𝗲𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟰 is just around the corner! Join us on October 30th at Forskningsparken - Oslo Science Park for a full day of insightful discussions on the future of life sciences. This year’s program is packed with sessions covering everything from AI in healthcare, women in health and disease, sustainable approaches to bioresources, and the future of nutrition. Connect with industry leaders who are advancing these fields and driving impactful change. 🔑 Key highlights include: • Keynotes from leading voices, including Ishita Barua, MD PhD, Sigrid Bratlie, Olav Kjørven and Roberto Spreafico. • Panels dicussion on life science export, women in health and disease, industry-academia collaborations, nutrition and sustainability, and investment in life science 📢 This is your last chance to secure tickets! Don’t miss out on the opportunity to connect, learn, and shape the future of life sciences. Register here: https://lnkd.in/dWTseusQ We look forward to welcoming you to InLifeScience 2024! Tekna | Hanne Mette Kristensen | Tone Juel | Benjamin Dyhre | Delphine Costa | Carl Henrik Görbitz | Eva Veiseth-Kent | Terje Hekkelstrand | Marius Widerøe

Fremdeles noen ledige plasser på InLifeScience 2024 på onsdag 30. oktober! Møt kolleger, forskere, industrifolk, startups, instituttsektor, investorer og mange fler i økosystemet. Kvinners helse er et av temaene: hvordan står det til med forskning på kvinnesykdommer som endometriose, og hvordan står det til med sykdommer både kvinner og menn dør av, slik som hjerneslag? Hva er industriens syn på utvikling av nye medisiner for kvinner og menn? 'Diagnose Kvinne' er tittelen på en av panelistenes siste bok. Her blir det spennende samtaler - vi sees! Hanne Haslene-Hox Else Charlotte Sandset Liv Bjørnhaug Johansen Kristin Janett Løseth SINTEF AstraZeneca Universitetet i Oslo (UiO) Norske Kvinners Sanitetsforening Carl Henrik Görbitz Terje Hekkelstrand Eva Veiseth-Kent Marius Widerøe Ørjan Leiknes Apeland The Life Science Cluster Tekna

Tirsdag morgen organiserte Venstre, Norges Liberale Parti i samarbeid med stortingets tech-gruppe, Langsikt, SINTEF og CEPI (Coalition for Epidemic Preparedness Innovations) et seminar på Stortinget om "tvillingrevolusjonene" bioteknologi og KI. Det ble satt søkelys på både muligheter og trusler som teknologiene kan bringe med seg. Sammen med SINTEF, NORCE Norwegian Research Centre, Langsikt, Abelia, NCE Heidner Biocluster og Bellona etterlyser vi en nasjonal strategi for bioinnovasjon. Bioteknologien er allerede blant de raskest voksende industriene globalt. Det spås at bioøkonomien innen 2040 kan vokse til 30 billioner dollar (https://lnkd.in/d7tPf2DA). Ny teknologi utviklet innen bioinnovasjon kan brukes til å utvikle og produsere nye medisiner raskere, smartere og mer bærekraftig. Potensialet for nyskapende bioinnovasjoner er minst like stort i andre sektorer, særlig der biologiske innsatsfaktorer utgjør grunnlaget i verdikjeden. Mer klimavennlig, dyrevennlig og arealeffektiv matproduksjon, både på land og i havet, er blant områdene der bioteknologien vil være muliggjørende og få størst betydning. Også andre verdikjeder som ikke i dag er basert på biologi, vil påvirkes fundamentalt: Analyser viser at 60 prosent av alt mennesker fysisk forbruker, potensielt kan lages biologisk. Nye og mer bærekraftige materialer, industrielle råstoffer og nye typer drivstoff er eksempler. Les mer her: https://lnkd.in/de6aGy8c The Life Science Cluster er en medlemsklynge med over 120 medlemmer, og en nasjonal pådriver for å utvikle flere løsninger for samfunnet, og mer innovasjon og industri innenfor livsvitenskap. Dette omfatter både helse og bioindustri. Våren 2024 ble helse pekt ut som vår nyeste nasjonale eksportsatsing - på høy tid! Nå følger vi opp mulighetene innenfor bioinnovasjon på en bredere plattform som en neste nasjonal satsing. Håvard Sletta, Sigrid Bratlie, Gurill Narum Mediaa, Stig Tollefsen, Nils-Ola Widme, Delphine Costa, Benjamin Dyhre Alfred Bjørlo

🌱 𝗜𝗻𝗟𝗶𝗳𝗲𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟰: 𝗦𝗲𝗰𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 📆 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟬𝘁𝗵, Forskningsparken - Oslo Science Park We’re thrilled to feature Roberto Spreafico, Senior Director of Discovery Data Science at Genmab, as one of our keynote speakers at InLifeScience 2024. With over 12 years of experience in AI-driven research and a background in immunology and bioinformatics, Roberto will present "Pioneering Data-Driven Strategies in De Novo Nanobody Design". Roberto's expertise spans genomics, bioinformatics, and artificial intelligence, making him a leader in applying data science to breakthrough treatments. Since joining Genmab in 2022, Roberto has been driving innovative research in cancer therapies and antibody engineering, aligning with Genmab’s goal of developing antibody therapeutics for cancer and other serious diseases. In addition to his keynote, Roberto will join the panel discussion on industry and academia collaboration, highlighting the importance of partnerships in advancing life sciences.   Join us on 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟬𝘁𝗵 at InLifeScience 2024 to hear from Roberto and other leading voices in the life science field. We're proud of this year's InLifeScience 2024 program and have reduced the ticket price to make it more accessible for those interested in attending. 🌟 Full program and registration: https://lnkd.in/dt7Bqcpc Tekna | Hanne Mette Kristensen | Tone Juel | Benjamin Dyhre | Delphine Costa | Carl Henrik Görbitz | Eva Veiseth-Kent | Terje Hekkelstrand | Marius Widerøe

🌱 𝗜𝗻𝗟𝗶𝗳𝗲𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟰: 𝗦𝗲𝗰𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 📆 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟬𝘁𝗵, Forskningsparken - Oslo Science Park We’re excited to present the panel "Women in health and disease: is research overlooking half the population?" at InLifeScience 2024. This discussion will focus on how gender biases may impact health research and care, and what can be done to ensure equitable healthcare for all. 💡 Meet the Panelists: Hanne Haslene-Hox is a Senior Research Scientist at SINTEF, with extensive experience in developing advanced cell models and bioengineering processes. She leads the newly launched project focused on endometriosis, a widespread women’s health issue, aiming to improve diagnostics and treatment options for this often-overlooked condition. Liv Bjørnhaug Johansen, Senior Advisor at the Norske Kvinners Sanitetsforening, is also a nurse and author. In 2023, she published "Diagnose: kvinne", where she explores gender biases in healthcare through women’s stories, research, and history, illustrating how these disparities affect women’s health in various ways. Kristin Janett Løseth is the Country Medical Director at AstraZeneca, with over 20 years of experience in various leadership roles within the company. She is part of the Nordic Medical & Regulatory Leadership Team and serves on AstraZeneca’s board. Else Charlotte Sandset, Medical Doctor and Consultant Neurologist at Oslo University Hospital (OUS), she is the chair of stroke and general neurology at OUS, Ullevål. Her research focuses on improving stroke care, and is a founding member of the Women's Initiative for Stroke in Europe. She has multiple publications on sex differences in stroke, represenation of women in stroke trials, and of women in the stroke scientific community We're proud of this year's InLifeScience 2024 program and have reduced the ticket price to make it more accessible for those interested in attending. 🌟 Full program and registration: https://lnkd.in/dt7Bqcpc Tekna | Hanne Mette Kristensen | Tone Juel | Benjamin Dyhre | Delphine Costa | Carl Henrik Görbitz | Eva Veiseth-Kent | Terje Hekkelstrand | Marius Widerøe

🔬 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗡𝗲𝘂𝗿𝗼𝗽𝗮𝘁𝗵𝗶𝗰 𝗣𝗮𝗶𝗻 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 AKIGAI is pushing the boundaries of biotech by repurposing EGFR inhibitors, originally used in cancer care, to treat neuropathic pain. With groundbreaking discoveries, regulatory approvals, and a focus on conditions like Complex Regional Pain Syndrome (CRPS), they are poised to transform pain management for millions. Learn more about their journey, upcoming trials, and the innovative solutions they're bringing to the field, led by co-founder Christian Kersten, MD PhD, in our latest Start-up Spotlight article. This article series is produced in collaboration with the Norwegian health clusters Oslo Cancer Cluster, Norway Health Tech, Norwegian Smart Care Cluster, The Life Science Cluster, and Biotech North. 🌟 Read the full story here: https://lnkd.in/dXMYZSmr

🌱 𝗜𝗻𝗟𝗶𝗳𝗲𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝟮𝟬𝟮𝟰: 𝗦𝗲𝗰𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲 📆 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟬𝘁𝗵, Forskningsparken - Oslo Science Park We’re excited to present the panel "Life Science Export – A Culture for Nurturing Scaleups" at InLifeScience 2024, diving into how Norway can better support life science companies in helping them scale and thrive in global markets. 💡 Meet the Panelists: Stefan Kernstock, CEO of SERO AS - The independent control sera specialist, will share insights from SERO’s journey as a scale-up in the medical diagnostics sector. Torsten Knüttel, Vice President of R&D at Gentian Diagnostics focuses on developing and exporting diagnostic tools for diseases like kidney and cardiac conditions, helping laboratories improve efficiency globally. Mia Louise Kråkstad, Healthcare Director at IQVIA Nordics, helps life science companies scale through data-driven insights and technology solutions tailored to the healthcare sector. 🎤 Moderated by: Tone Varslot Stave, Head of Health at Innovation Norway, brings 15 years of experience in managing risk and operations across sectors, helping support the growth of Norway’s life science industry. Join us on 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟬𝘁𝗵 for InLifeScience 2024. 🌟 Full program and registration: https://lnkd.in/dt7Bqcpc Tekna | Hanne Mette Kristensen | Tone Juel | Benjamin Dyhre | Delphine Costa | Carl Henrik Görbitz | Eva Veiseth-Kent | Terje Hekkelstrand | Marius Widerøe